284 related articles for article (PubMed ID: 16882812)
1. Screening for celiac disease in asymptomatic children with Down syndrome: cost-effectiveness of preventing lymphoma.
Swigonski NL; Kuhlenschmidt HL; Bull MJ; Corkins MR; Downs SM
Pediatrics; 2006 Aug; 118(2):594-602. PubMed ID: 16882812
[TBL] [Abstract][Full Text] [Related]
2. Screening for celiac disease in asymptomatic children with Down syndrome: cost-effectiveness of preventing lymphoma.
Kawatu D; LeLeiko NS
Pediatrics; 2006 Aug; 118(2):816-7. PubMed ID: 16882844
[No Abstract] [Full Text] [Related]
3. Genetic testing before serologic screening in relatives of patients with celiac disease as a cost containment method.
Chang M; Green PH
J Clin Gastroenterol; 2009 Jan; 43(1):43-50. PubMed ID: 19020464
[TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness of screening for hereditary hemochromatosis.
Phatak PD; Guzman G; Woll JE; Robeson A; Phelps CE
Arch Intern Med; 1994 Apr; 154(7):769-76. PubMed ID: 8147681
[TBL] [Abstract][Full Text] [Related]
5. Accuracy and cost-effectiveness of a new strategy to screen for celiac disease in children with Down syndrome.
Csizmadia CG; Mearin ML; Oren A; Kromhout A; Crusius JB; von Blomberg BM; Peña AS; Wiggers MN; Vandenbroucke JP
J Pediatr; 2000 Dec; 137(6):756-61. PubMed ID: 11113830
[TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness of alternative strategies for tuberculosis screening before kindergarten entry.
Flaherman VJ; Porco TC; Marseille E; Royce SE
Pediatrics; 2007 Jul; 120(1):90-9. PubMed ID: 17606566
[TBL] [Abstract][Full Text] [Related]
7. First- and second-trimester evaluation of risk for Down syndrome.
Ball RH; Caughey AB; Malone FD; Nyberg DA; Comstock CH; Saade GR; Berkowitz RL; Gross SJ; Dugoff L; Craigo SD; Timor-Tritsch IE; Carr SR; Wolfe HM; Emig D; D'Alton ME;
Obstet Gynecol; 2007 Jul; 110(1):10-7. PubMed ID: 17601890
[TBL] [Abstract][Full Text] [Related]
8. Serological testing for coeliac disease in patients with symptoms of irritable bowel syndrome: a cost-effectiveness analysis.
Mein SM; Ladabaum U
Aliment Pharmacol Ther; 2004 Jun; 19(11):1199-210. PubMed ID: 15153173
[TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness analysis of screening for celiac disease in the adult population.
Shamir R; Hernell O; Leshno M
Med Decis Making; 2006; 26(3):282-93. PubMed ID: 16751327
[TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness of screening for hepatopulmonary syndrome in liver transplant candidates.
Roberts DN; Arguedas MR; Fallon MB
Liver Transpl; 2007 Feb; 13(2):206-14. PubMed ID: 17205561
[TBL] [Abstract][Full Text] [Related]
11. Long-term health and quality-of-life consequences of mass screening for childhood celiac disease: a 10-year follow-up study.
van Koppen EJ; Schweizer JJ; Csizmadia CG; Krom Y; Hylkema HB; van Geel AM; Koopman HM; Verloove-Vanhorick SP; Mearin ML
Pediatrics; 2009 Apr; 123(4):e582-8. PubMed ID: 19336349
[TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness model for first-trimester versus second-trimester ultrasound screening for Down syndrome.
Kott B; Dubinsky TJ
J Am Coll Radiol; 2004 Jun; 1(6):415-21. PubMed ID: 17411619
[TBL] [Abstract][Full Text] [Related]
13. Prospective human leukocyte antigen, endomysium immunoglobulin A antibodies, and transglutaminase antibodies testing for celiac disease in children with Down syndrome.
Wouters J; Weijerman ME; van Furth AM; Schreurs MW; Crusius JB; von Blomberg BM; de Baaij LR; Broers CJ; Gemke RJ
J Pediatr; 2009 Feb; 154(2):239-42. PubMed ID: 18822429
[TBL] [Abstract][Full Text] [Related]
14. Cost-effectiveness of neonatal ECG screening for the long QT syndrome.
Quaglini S; Rognoni C; Spazzolini C; Priori SG; Mannarino S; Schwartz PJ
Eur Heart J; 2006 Aug; 27(15):1824-32. PubMed ID: 16840497
[TBL] [Abstract][Full Text] [Related]
15. Cost-effectiveness of coronary artery disease screening in asymptomatic patients with type 2 diabetes and other atherogenic risk factors in Japan: factors influencing on international application of evidence-based guidelines.
Hayashino Y; Shimbo T; Tsujii S; Ishii H; Kondo H; Nakamura T; Nagata-Kobayashi S; Fukui T
Int J Cardiol; 2007 May; 118(1):88-96. PubMed ID: 16949690
[TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness analysis of prenatal population-based fragile X carrier screening.
Musci TJ; Caughey AB
Am J Obstet Gynecol; 2005 Jun; 192(6):1905-12; discussion 1912-5. PubMed ID: 15970847
[TBL] [Abstract][Full Text] [Related]
17. Long-term effectiveness and cost-effectiveness of screening for hepatitis C virus infection.
Sroczynski G; Esteban E; Conrads-Frank A; Schwarzer R; Mühlberger N; Wright D; Zeuzem S; Siebert U
Eur J Public Health; 2009 Jun; 19(3):245-53. PubMed ID: 19196737
[TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness of screening strategies for Gonorrhea among females in private sector care.
Bernstein KT; Mehta SD; Rompalo AM; Erbelding EJ
Obstet Gynecol; 2006 Apr; 107(4):813-21. PubMed ID: 16582117
[TBL] [Abstract][Full Text] [Related]
19. Celiac disease screening in 100 Turkish children with Down syndrome.
Alanay Y; Boduroğlu K; Tunçbilek E
Turk J Pediatr; 2005; 47(2):138-40. PubMed ID: 16052853
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of celiac disease in Tunisia: mass-screening study in schoolchildren.
Ben Hariz M; Kallel-Sellami M; Kallel L; Lahmer A; Halioui S; Bouraoui S; Laater A; Sliti A; Mahjoub A; Zouari B; Makni S; Maherzi A
Eur J Gastroenterol Hepatol; 2007 Aug; 19(8):687-94. PubMed ID: 17625439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
